Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.

We get the rundown on mRNA vaccine manufacturing. How were the vaccines developed so quickly?

Exploring the importance of viscosity in pharmaceutical product design.

What are the challenges of ensuring COVID-19 vaccine access worldwide?

COVID-19 has put the spotlight on the weaknesses of today’s highly dispersed, globalized pharma industry. Is onshoring the answer?

Let’s not ride roughshod over patient autonomy when it comes to national vaccination campaigns.

Kevin Ott from the BPSA says we should not forget how single-use plastics are saving lives.

How has COVID-19 consumer stockpiling affected the supply chains for pharma ingredients?

Abcam explains how giving workers more flexibility has been good for the business.

The EMA is looking for individuals to join its scientific advisory groups.